Related Experiment Video
Updated: Jun 15, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Working under pressure: coronary arteries and the endothelin system
Albert Nguyen1, Nathalie Thorin-Trescases, Eric Thorin
1Institut de Cardiologie de Montréal, centre de recherche, 5000 rue Bélanger, Montréal, Québec, Canada.
Endothelial dysfunction involves an imbalance between nitric oxide (NO) and endothelin-1 (ET-1). This study explores how receptor imbalances contribute to cardiovascular disease, suggesting potential therapeutic targets.
Area of Science:
- Cardiovascular physiology
- Endothelial function
- Pharmacology
Background:
- Endogenous endothelin-1 (ET-1) tone in coronary arteries is regulated by ET(A) and ET(B) receptors.
- Nitric oxide (NO) and ET-1 exhibit significant functional interactions in vascular tone regulation.
- Endothelial dysfunction, linked to cardiovascular risk factors and aging, involves dysregulation between NO and ET-1.
Purpose of the Study:
- To investigate the contribution of imbalanced smooth muscle ET(A/B) and endothelial ET(B) receptors to endothelial dysfunction.
- To understand the role of ET-1 and NO dysregulation in coronary endothelial dysfunction, vasospasm, and atherosclerosis.
- To provide a rationale for therapeutic strategies targeting ET-1-induced cardiovascular dysfunction.
Main Methods:
- Analysis of receptor distribution and endothelial integrity.
- Assessment of functional interactions between NO and ET-1.
- Evaluation of the impact of aging and cardiovascular risk factors on receptor function.
Main Results:
- Increased ET-1 contribution and decreased NO correlate with coronary endothelial dysfunction, vasospasm, and atherosclerosis.
- The balance between ET(A) and ET(B) receptors is crucial for endogenous ET-1 tone.
- Smooth muscle ET(B) receptors may exhibit proconstricting and proinflammatory activities under certain conditions.
Conclusions:
- Imbalance in ET-1 and NO signaling contributes significantly to cardiovascular complications.
- Therapeutic approaches counteracting ET-1 may be beneficial for cardiovascular dysfunction.
- The role of endothelial ET(B) receptors may diminish with age and disease, unmasking detrimental smooth muscle ET(B) receptor effects.
Related Concept Videos
Heart Failure II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

